High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Dongiovanni, Paola ^a   Lanti, Claudia ^b   Gatti, Stefano ^a   Rametta, Raffaela ^b   Recalcati, Stefania ^c   Maggioni, Marco ^a   Fracanzani, Anna Ludovica ^a,b   Riso, Patrizia ^b   Cairo, Gaetano ^c   Fargion, Silvia ^a,b   Valenti, Luca ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; ELAIDIC ACID; FERRITIN; FERROPORTIN 1; HEPCIDIN; IRON; IRON REGULATORY PROTEIN 1; LAURIC ACID; LINOLENIC ACID; OLEIC ACID; PALMITIC ACID; STEARIC ACID; FATTY ACID; TFR1 PROTEIN, RAT; TRANSFERRIN RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSMETABOLIC IRON OVERLOAD SYNDROME; FEMALE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; LIPID DIET; LIVER CELL; LIVER METABOLISM; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; ADVERSE EFFECTS; ANIMAL; DEFICIENCY; DRUG EFFECTS; GENE SILENCING; GENETICS; HEP-G2 CELL LINE; LIVER; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; SPRAGUE DAWLEY RAT; TRANSPORT AT THE CELLULAR LEVEL;

RATTUS;

ANIMALS; BIOLOGICAL TRANSPORT; DIET, HIGH-FAT; FATTY ACIDS; FEMALE; GENE SILENCING; HEP G2 CELLS; HEPATOCYTES; HUMANS; IRON; IRON OVERLOAD; IRON REGULATORY PROTEIN 1; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFERRIN; UP-REGULATION;

EID: 84922363060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116855     Document Type: Article

References (40)

1. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850. doi: 10.2337/diabetes.50.8.1844 PMID: 11473047
2. Edgren G, Reilly M, Hjalgrim H, Tran TN, Rostgaard K, et al. (2008) Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst 100: 572-579. doi: 10.1093/jnci/djn084 PMID: 18398098
3. Fernandez-Real JM, Ricart-Engel W, Arroyo E, Balanca R, Casamitjana-Abella R, et al. (1998) Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 21: 62-68. doi: 10.2337/ diacare.21.1.62 PMID: 9580307
4. Jehn M, Clark JM, Guallar E (2004) Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 27: 2422-2428. doi: 10.2337/diacare.27.10.2422 PMID: 15451911
5. Ramos P, Guy E, Chen N, Proenca CC, Gardenghi S, et al. (2011) Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis. Blood 117: 1379-1389. doi: 10.1182/blood-2010-09-307462 PMID: 21059897
6. Dongiovanni P, Fracanzani AL, Fargion S, Valenti L (2011) Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target. J Hepatol 55: 920-932. doi: 10.1016/j.jhep.2011.05.008 PMID: 21718726
7. Riva A, Trombini P, Mariani R, Salvioni A, Coletti S, et al. (2008) Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome. World J Gastroenterol 14: 4745-4752. doi: 10.3748/wjg.14.4745 PMID: 18720534
8. Dongiovanni P, Ruscica M, Benedan L, Borroni V, Recalcati S, et al. (2011) Dietary iron overload induces visceral adipose tissue insulin resistance associated with hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin resistance. J Hepatol 54: S505.
9. Gabrielsen JS, Gao Y, Simcox JA, Huang J, Thorup D, et al. (2012) Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 122: 3529-3540. doi: 10.1172/JCI44421 PMID: 22996660
10. Wlazlo N, van Greevenbroek MMJ, Ferreira I, Jansen EHJM, Feskens EJ, et al. (2012) Iron Metabolism Is Associated With Adipocyte Insulin Resistance and Plasma Adiponectin. Diabetes Care: ePub ahead of print.
11. Facchini FS, Hua NW, Stoohs RA (2002) Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 122: 931-939. doi: 10.1053/ gast.2002.32403 PMID: 11910345
12. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, et al. (2007) Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol 102: 1251-1258. doi: 10.1111/j.1572- 0241.2007.01192.x PMID: 17391316
13. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, et al. (2001) Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 96: 2448-2455. doi: 10.1111/j.1572-0241.2001.04052.x PMID: 11513189
14. Valenti L, Fracanzani A, Bugianesi E, Dongiovanni P, Galmozzi E, et al. (2010) HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 138: 905-912. doi: 10.1053/j.gastro.2009.11.013 PMID: 19931264
15. Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, et al. (2012) Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 55: 77-85. doi: 10.1002/hep.24706 PMID: 21953442
16. Valenti L, Canavesi E, Galmozzi E, Dongiovanni P, Rametta R, et al. (2010) Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol 53: 927-933. doi: 10.1016/j.jhep.2010.05.023 PMID: 20739079
17. Valenti L, Swinkels DW, Burdick L, Dongiovanni P, Tjalsma H, et al. (2010) Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc: in press.
18. Valenti L, Dongiovanni P, Motta BM, Swinkels DW, Bonara P, et al. (2011) Serum Hepcidin and Macrophage Iron Correlate With MCP-1 Release and Vascular Damage in Patients With Metabolic Syndrome Alterations. Arterioscler Thromb Vasc Biol 31: 683-690. doi: 10.1161/ATVBAHA.110.214858 PMID: 21183736
19. Martinelli N, Traglia M, Campostrini N, Biino G, Corbella M, et al. (2012) Serum hepcidin levels in subjects with the metabolic syndrome. A population study. PLOS ONE 7: e48250. doi: 10.1371/journal. pone.0048250 PMID: 23144745
20. Aigner E, Theurl I, Haufe H, Seifert M, Hohla F, et al. (2008) Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Gastroenterology 135: 680-688. doi: 10.1053/j. gastro.2008.04.007 PMID: 18505688
21. Barisani D, Pelucchi S, Mariani R, Galimberti S, Trombini P, et al. (2008) Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload. J Hepatol 49: 123-133. doi: 10. 1016/j.jhep.2008.03.011 PMID: 18462824
22. Aigner E, Theurl I, Theurl M, Lederer D, Haufe H, et al. (2008) Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am J Clin Nutr 87: 1374-1383. PMID: 18469261
23. Valenti L, Rametta R, Dongiovanni P, Motta BM, Canavesi E, et al. (2012) The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease. PLoS One 7: e48804. doi: 10.1371/journal.pone.0048804 PMID: 23144979
24. Svegliati-Baroni G, Candelaresi C, Saccomanno S, Ferretti G, Bachetti T, et al. (2006) A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor- alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 169: 846-860. doi: 10.2353/ajpath.2006.050953 PMID: 16936261
25. Barry M, Sherlock S (1971) Measurement of liver iron concentration in needle biopsy specimens. Lancet 1: 100-103. doi: 10.1016/S0140-6736(71)90838-5 PMID: 4099600
26. Cairo G, Tacchini L, Pogliaghi G, Anzon E, Tomasi A, et al. (1995) Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. J Biol Chem 270: 700-703. doi: 10.1074/jbc.270.2.700 PMID: 7822298
27. Dongiovanni P, Fracanzani A, Cairo G, Megazzini CP, Gatti S, et al. (2010) Iron dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis. Am J Pathol 176: in press. doi: 10.2353/ ajpath.2010.090249 PMID: 20019189
28. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321. doi: 10.1002/ hep.20701 PMID: 15915461
29. Scheuer PG, Williams R, Muir AR (1962) Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol 84: 53-64. doi: 10.1002/path.1700840107 PMID: 14498313
30. Papanikolaou G, Pantopoulos K (2005) Iron metabolism and toxicity. Toxicol Appl Pharmacol 202: 199-211. doi: 10.1016/j.taap.2004.06.021 PMID: 15629195
31. Cohen JC, Horton JD, Hobbs HH (2011) Human fatty liver disease: old questions and new insights. Science 332: 1519-1523. doi: 10.1126/science.1204265 PMID: 21700865
32. Camaschella C, Silvestri L (2011) Molecular mechanisms regulating hepcidin revealed by hepcidin disorders. ScientificWorldJournal 11: 1357-1366. doi: 10.1100/tsw.2011.130 PMID: 21789471
33. Ganz T (2012) Macrophages and systemic iron homeostasis. J Innate Immun 4: 446-453. doi: 10. 1159/000336423 PMID: 22441209
34. Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Hosoki Y, et al. (2005) Iron accumulation in alcoholic liver diseases. Alcohol Clin Exp Res 29: 189S-193S. doi: 10.1097/01.alc.0000189274.00479.62 PMID: 16344607
35. Cairo G, Pietrangelo A (2000) Iron regulatory proteins in pathobiology. Biochem J 352 Pt 2: 241-250. doi: 10.1042/0264-6021:3520241 PMID: 11085915
36. Meli R, Mattace Raso G, Irace C, Simeoli R, Di Pascale A, et al. (2013) High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats. PLoS One 8: e66570. PMID: 23805238
37. Ahmed U, Oates PS (2013) Dietary fat level affects tissue iron levels but not the iron regulatory gene HAMP in rats. Nutr Res 33: 126-135. doi: 10.1016/j.nutres.2012.11.012 PMID: 23399663
38. Sonnweber T, Ress C, Nairz M, Theurl I, Schroll A, et al. (2012) High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption. J Nutr Biochem 23: 1600-1608. doi: 10. 1016/j.jnutbio.2011.10.013 PMID: 22444869
39. Montosi G, Corradini E, Garuti C, Barelli S, Recalcati S, et al. (2005) Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. Hepatology 41: 545-552. doi: 10. 1002/hep.20620 PMID: 15726660
40. Bu W, Liu R, Cheung-Lau JC, Dmochowski IJ, Loll PJ, et al. (2012) Ferritin couples iron and fatty acid metabolism. FASEB J 26: 2394-2400. doi: 10.1096/fj.11-198853 PMID: 22362897